癌症/心脏病监测与预防的生物标志物：传统与创新视角 - Suppr

Suppr

超能文献

Biomarkers for monitoring and prevention in cancer/heart disease: Traditional and innovative perspectives.

作者信息

Vasbinder Alexi, Hayek Salim S

机构信息

Division of Cardiology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.

出版信息

Am Heart J Plus. 2022 Jun 27;17:100161. doi: 10.1016/j.ahjo.2022.100161. eCollection 2022 May.

DOI:10.1016/j.ahjo.2022.100161

PMID:38559881

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10978318/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f3/10978318/34263e7092ea/gr1.jpg

相似文献

Biomarkers for monitoring and prevention in cancer/heart disease: Traditional and innovative perspectives.

Am Heart J Plus. 2022 Jun 27;17:100161. doi: 10.1016/j.ahjo.2022.100161. eCollection 2022 May.

Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: clinical evidence and perspectives.

Eur J Intern Med. 2011 Oct;22(5):460-5. doi: 10.1016/j.ejim.2011.02.023. Epub 2011 Mar 25.

Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.

J Nucl Cardiol. 2013 Jun;20(3):443-64. doi: 10.1007/s12350-013-9707-1.

Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure.

Biomolecules. 2024 Mar 6;14(3):309. doi: 10.3390/biom14030309.

A Changing Paradigm in Heart Transplantation: An Integrative Approach for Invasive and Non-Invasive Allograft Rejection Monitoring.

Biomolecules. 2021 Feb 1;11(2):201. doi: 10.3390/biom11020201.

MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.

Int J Mol Sci. 2022 Jul 20;23(14):7991. doi: 10.3390/ijms23147991.

Current progress, strategy, and prospects of PD-1/PDL-1 immune checkpoint biosensing platforms for cancer diagnostics, therapy monitoring, and drug screening.

Biosens Bioelectron. 2023 Nov 15;240:115644. doi: 10.1016/j.bios.2023.115644. Epub 2023 Aug 28.

Circulating cardiac biomarkers, structural brain changes, and dementia: Emerging insights and perspectives.

Alzheimers Dement. 2023 Apr;19(4):1529-1548. doi: 10.1002/alz.12926. Epub 2023 Feb 3.

Implementation of a "County-Township-Village" Allied HIV Prevention and Control Intervention in Rural China.

AIDS Patient Care STDS. 2017 Sep;31(9):384-393. doi: 10.1089/apc.2017.0113.

Biomarkers versus traditional risk factors to predict cardiovascular events in very old adults: cross-validated prospective cohort study.

BMJ Open. 2020 Jun 28;10(6):e035809. doi: 10.1136/bmjopen-2019-035809.

本文引用的文献

Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

J Am Coll Cardiol. 2017 Jul 11;70(2):152-162. doi: 10.1016/j.jacc.2017.05.019.

Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy.

J Am Heart Assoc. 2017 Apr 4;6(4):e004653. doi: 10.1161/JAHA.116.004653.

Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy.

J Clin Oncol. 2017 Mar 10;35(8):878-884. doi: 10.1200/JCO.2015.65.7916. Epub 2016 Oct 23.

Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.

Clin Chem. 2015 Sep;61(9):1164-72. doi: 10.1373/clinchem.2015.241232. Epub 2015 Jul 27.

New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide.

Biomarkers. 2015 Mar;20(2):143-8. doi: 10.3109/1354750X.2015.1040839. Epub 2015 May 18.

Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.

Clin Cancer Res. 2014 Dec 15;20(24):6314-23. doi: 10.1158/1078-0432.CCR-13-3490. Epub 2014 Jun 19.

Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.

J Am Coll Cardiol. 2014 Mar 4;63(8):809-16. doi: 10.1016/j.jacc.2013.10.061. Epub 2013 Nov 27.

Growth-differentiation factor-15 and tissue doppler ımaging in detection of asymptomatic anthracycline cardiomyopathy in childhood cancer survivors.

Clin Biochem. 2013 Sep;46(13-14):1239-43. doi: 10.1016/j.clinbiochem.2013.06.029. Epub 2013 Jul 11.

High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study.

Breast Cancer Res Treat. 2012 Jul;134(1):291-8. doi: 10.1007/s10549-012-2039-z. Epub 2012 Apr 4.

Prediction of anthracycline cardiotoxicity after chemotherapy by biomarkers kinetic analysis.

Cardiovasc Toxicol. 2012 Jun;12(2):135-42. doi: 10.1007/s12012-011-9149-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验